HIV prevention shots coming to your local pharmacy?
NCT ID NCT07210125
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a long-acting HIV prevention shot (lenacapavir) in community pharmacies is practical and acceptable. Seventy-five HIV-negative adults will receive the injection either twice a year or every three months, and researchers will track how many stay on the regimen and whether STI rates change. The goal is to see if pharmacies can help more people access this prevention option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lenacapavir (long-acting injectable)
What this could lead to
If successful, this could show that community pharmacies are a convenient and effective place to deliver long-acting HIV prevention shots, potentially expanding access and reducing HIV infections.
What could go wrong
This is a small, single-center study with only 75 participants, so results may not apply broadly. It focuses on feasibility and acceptability, not on directly proving the drug prevents HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kelley-Ross Pharmacy
Seattle, Washington, 98122, United States